# Omega-3 Fatty Acid Administration in Dialysis Patients

> **NCT00655525** · PHASE2 · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 38 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DIETARY_SUPPLEMENT:** fish oil
- **DIETARY_SUPPLEMENT:** placebo

## Key facts

- **NCT ID:** NCT00655525
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2014-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00655525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00655525, "Omega-3 Fatty Acid Administration in Dialysis Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00655525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*